Beyond the Bench: Demystifying Clinical Trials and the Future Role of Community PharmacyNovember 20, 2025 MORE
Unlocking Community-Based Trials: Major Takeaways from the Inaugural RxE2 Un-ConferenceNovember 5, 2025 MORE
Engineering the Future of Community-Based Trials: How RxE2 is Bringing Clinical Research to the Community PharmacyNovember 4, 2025 MORE
Celebrating Trust and Innovation: Closing American Pharmacists Month with Teresa Gerbig, PharmDOctober 28, 2025 MORE
Celebrating the Women Pharmacists of RxE2: A Conversation with Shavon Singh, PharmDOctober 12, 2025 MORE
Celebrating American Pharmacists Month: Featuring Tina Schlecht, PharmD, Chief Pharmacy Officer, RxE2October 1, 2025 MORE
Redefining Community Pharmacy: An Interview with Dr. Anthony Bolus, Clinical Coordinator at Family Medical ServicesAugust 12, 2025 MORE
Driving Innovation and Patient Care: A Conversation with Pharmacist Jenna Eccles of Wheat Ridge Professional PharmacyMay 26, 2025 MORE
RxE2 named one of the best Tech Startups in North Dakota for the 3rd year in a row !November 30, 2024 MORE
The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the PatientNovember 24, 2024 MORE
RxE2 Direct-to-Patient IP Dispensing for a Dose-Ranging Phase 1/2 Decentralized Clinical TrialApril 21, 2024 MORE
Enhancing Patient Recruitment through Community Pharmacies for a Phase 2 Neurological StudyJanuary 29, 2024 MORE
RxE2 Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and MarketplaceDecember 4, 2023 MORE
Moving the Needle: How the Practice of Pharmacy Addresses Key Issues in Clinical ResearchSeptember 17, 2022 MORE
RxE2 Founder and CEO Gerald Finken on the Role and Value of Pharmacists in Clinical ResearchSeptember 6, 2022 MORE
The Impact of Decentralized Clinical Trials on the Investigational Drug Supply Chain: Making Clinical Supplies Patient-CentricApril 20, 2021 MORE
RxE2 CEO and Two-Time USA Cycling Masters Nationals Champion Gerald Finken Donates $27,500 to NorthStar Development Cycling ClubFebruary 2, 2021 MORE
RxE2 Agrees to Acquire Habitu to Form the First AI Driven, Pharmacist-Led, Clinical Trial PlatformJanuary 11, 2021 MORE
RxE2 and Newdays Pharmacy Expand E2 Dispensing Service for Clinical Drug Trials to the EU and UKAugust 3, 2020 MORE
RxE2 and Thrifty White Pharmacy Establish First E2 Dispensing Service for Clinical Drug Trials in the USJuly 13, 2020 MORE
